drugset / Trial / NCT05481151
A Study to Assess Efficacy, Safety, and Tolerability of P1101 in Adult Patients With PV
RandomizedParallel-groupOpen-labelTreatment
Summary
A Study to Assess Efficacy, Safety, and Tolerability of P1101 in Adult Patients with PV
Timeline
- Start
- 2022-10-26
- Primary completion
- 2025-06-30
- Completion
- 2027-07-31
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Ropeginterferon alfa-2b | Protein / enzyme biologic | 500 ug | Subcutaneous |